Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance.

Shin YK, Yoo BC, Hong YS, Chang HJ, Jung KH, Jeong SY, Park JG.

Electrophoresis. 2009 Jun;30(12):2182-92. doi: 10.1002/elps.200800806.

PMID:
19582719
2.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

3.

hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells.

Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S.

Cancer Biol Ther. 2009 Apr;8(7):627-35. Epub 2009 Apr 22.

PMID:
19242126
4.

The impact of O2 availability on human cancer.

Bertout JA, Patel SA, Simon MC.

Nat Rev Cancer. 2008 Dec;8(12):967-75. doi: 10.1038/nrc2540. Epub 2008 Nov 6. Review.

5.

Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.

Tanaka T, Watanabe T, Kazama Y, Tanaka J, Kanazawa T, Kazama S, Nagawa H.

Br J Cancer. 2006 Dec 4;95(11):1562-7. Epub 2006 Nov 7.

6.

Cancer's molecular sweet tooth and the Warburg effect.

Kim JW, Dang CV.

Cancer Res. 2006 Sep 15;66(18):8927-30. Review.

7.

SMAD4 levels and response to 5-fluorouracil in colorectal cancer.

Alhopuro P, Alazzouzi H, Sammalkorpi H, Dávalos V, Salovaara R, Hemminki A, Järvinen H, Mecklin JP, Schwartz S Jr, Aaltonen LA, Arango D.

Clin Cancer Res. 2005 Sep 1;11(17):6311-6.

8.

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD.

J Clin Invest. 2005 Jul;115(7):1765-76. Epub 2005 Jun 16.

9.

Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P.

Cancer Res. 2005 Jan 15;65(2):613-21.

10.

Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.

Reinacher-Schick A, Baldus SE, Romdhana B, Landsberg S, Zapatka M, Mönig SP, Hölscher AH, Dienes HP, Schmiegel W, Schwarte-Waldhoff I.

J Pathol. 2004 Apr;202(4):412-20.

PMID:
15095268
11.

Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Derynck R, Zhang YE.

Nature. 2003 Oct 9;425(6958):577-84. Review.

PMID:
14534577
12.

Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.

Duda DG, Sunamura M, Lefter LP, Furukawa T, Yokoyama T, Yatsuoka T, Abe T, Inoue H, Motoi F, Egawa S, Matsuno S, Horii A.

Oncogene. 2003 Oct 9;22(44):6857-64.

PMID:
14534532
13.

Role of Smad4 (DPC4) inactivation in human cancer.

Miyaki M, Kuroki T.

Biochem Biophys Res Commun. 2003 Jul 11;306(4):799-804. Review.

PMID:
12821112
14.

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.

Barratt PL, Seymour MT, Stenning SP, Georgiades I, Walker C, Birbeck K, Quirke P; UKCCCR AXIS trial collaborators. Adjuvant X-ray and Fluorouracil Infusion Study.

Lancet. 2002 Nov 2;360(9343):1381-91.

PMID:
12423985
15.

Frequent loss of SMAD4/DPC4 protein in colorectal cancers.

Salovaara R, Roth S, Loukola A, Launonen V, Sistonen P, Avizienyte E, Kristo P, Järvinen H, Souchelnytskyi S, Sarlomo-Rikala M, Aaltonen LA.

Gut. 2002 Jul;51(1):56-9.

16.

Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB 3rd, Hamilton SR.

N Engl J Med. 2001 Apr 19;344(16):1196-206.

17.
18.

Mechanisms underlying losses of heterozygosity in human colorectal cancers.

Thiagalingam S, Laken S, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B, Lengauer C.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2698-702. Epub 2001 Feb 13.

19.

Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.

Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A.

J Biol Chem. 2001 Mar 23;276(12):9519-25. Epub 2000 Dec 18.

20.

Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Maitra A, Molberg K, Albores-Saavedra J, Lindberg G.

Am J Pathol. 2000 Oct;157(4):1105-11.

Supplemental Content

Support Center